17 KB202 KB15 KB200820252010Jamnik, Helena4 straniletnik:9str. 43-46številka:suplement 2COBISSID:1047657ISSN:1580-9315URN:URN:NBN:SI:doc-QZTPX0P5slUniverzitetni rehabilitacijski inštitut Slovenije - SočaRehabilitacija (Ljubljana)fibromialgijanevropatska bolečinatherapyzdravljenjeMiofacialni bolečinski sindrom in sindrom fibromialgije| Myofascial pain syndrome and fibromyalgia syndrome| Nonpharmacological treatment of chronic low back pain| practice and possibilities for treatment| razlikovanje v klinični praksi in možnosti obravnave|Fibromyalgia is a chronic syndrome that is characterized by widespread body pain. The prevalence of fibromyalgia syndrome in the general population is estimated to be 2-7%. Chronic pain is often associated with comorbidities suchas depression, chronic fatigue, anxiety. With the new evidence regarding the pathophysiology of the fibromyalgia syndrome, it has been suggested that it may be one of the neuropathic pain syndromes. Although the pathogenesis is not completely understood, it has been suggested that peripheral or central hyperexcitability at the level of spinal cord or brainstem is involved. Drugs that are successful in the treatment of neuropathic pain syndromes have also been tested for fibromyalgia. These medications include antidepressants and other neuromodulators, as well as other analgesics. Dopamine agonists are suitable for patients with fibromyalgia especially if they report restless leg syndrome. The use of conventional analgesics is not recommended. Nonfarmacological measures are also important in fibromyalgia syndromeTEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaUniverzitetni rehabilitacijski inštitut RS – Soča